MG emerges as top predictor of complications after thymus surgery
Researchers develop model to predict patient risk after thymoma treatment
Written by |
- Myasthenia gravis is the strongest predictor of postoperative complications following thymus tumor removal surgery.
- Additional risk factors include advanced tumor stage, greater blood loss, reduced lung function, and low albumin levels.
- Researchers developed a predictive risk model to help clinicians personalize patient management and improve surgical outcomes.
Myasthenia gravis (MG) is the strongest predictor of complications after a thymectomy, a surgery to remove a tumor of the thymus gland, according to a study in China.
The risk of post-surgery complications was more than seven times higher in people with MG. Other factors independently associated with complication risk were a more advanced tumor stage, greater blood loss during surgery, poorer lung function, and lower albumin levels. Albumin is a protein made by the liver; low levels may be associated with poorer nutritional status and problems such as impaired wound healing.
The researchers used these five factors to develop a risk-prediction model that showed good ability to distinguish patients who developed complications from those who didn’t.
“If validated, this model could support personalized postoperative [post-surgery] management strategies, potentially improving clinical outcomes,” they wrote.
The study, “Development and validation of a predictive model for postoperative complications in thymoma patients,” was published in the Journal of Cardiothoracic Surgery.
Complications common after surgery
MG is an autoimmune disease in which the immune system disrupts communication between nerves and muscles, leading to MG symptoms such as muscle weakness and fatigue. The thymus, a part of the immune system, is frequently abnormal in people with MG, and some patients develop thymus tumors (thymomas).
Surgery is the mainstay treatment for thymoma, but postsurgery complications occur in up to nearly half of all cases. These may include breathing problems, infections, and bleeding.
The team of researchers at Beijing Chest Hospital sought to develop a model that could estimate the likelihood of complications after thymoma surgery and potentially help clinicians identify high-risk patients before surgery.
They retrospectively analyzed medical records from 253 people who underwent thymoma resection at their hospital between June 2006 and July 2024. Data from 177 people were used to develop the tool (modeling group), while data from the remaining 76 people were used to validate it (validation group).
More than half of all the participants (53.4% ) had co-existing health conditions; Thirty (11.9%) had MG.
Overall, 66 people (26.1%) experienced postoperative complications. There were 33 cases of respiratory failure and 26 infections, two deaths within 30 days of surgery, three cases of heart failure, and one case each of liver and kidney dysfunction.
MG was significantly more common among people who experienced complications than among those who didn’t (24.2% vs. 7.5%).
Statistical analyses accounting for potential influencing factors identified MG as the strongest independent predictor of postsurgery complications, associated with a seven times higher risk of complications.
Four other factors were independent predictors of complications: a more advanced tumor stage based on the Masaoka-Koga system, greater blood loss during surgery, lower lung function as measured by forced expiratory volume in one second (FEV1), and lower albumin levels.
The Masaoka-Koga system classifies thymomas based largely on how far they have invaded nearby tissues or spread. FEV1 measures how much air a person can forcefully exhale in the first second of a breath.
The team incorporated the five factors into a nomogram, a graphical tool that assigns points to individual risk factors to generate an estimated probability of developing complications.
The model showed an area under the curve (AUC) of 0.84 in the modeling group and 0.76 in the validation group. AUC is a statistical measure of how well a model distinguishes between patients who experience an outcome and those who do not. A value of 0.5 indicates performance no better than chance, while one indicates perfect discrimination.
The researchers said such a tool could eventually help clinicians tailor surgical and anesthesia plans and provide more intensive monitoring for people considered at high risk, though they emphasized that the prediction model is not yet ready for routine clinical use.
“While these results are promising, the model’s generalizability should be further confirmed through prospective, multicenter external validation involving diverse patient populations,” the team wrote.
Leave a comment
Fill in the required fields to post. Your email address will not be published.